Global Veterinary Dermatology Drugs Market 2024-2031

PUBLISHED: September 29, 2024

PAGES: 196 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report by Type (Antifungal Drugs, Antibacterial Drugs, and Antiparasitic Drugs), by Animal Type (Companion Animals and Livestock Animals), by Route of Administration (Topical, Oral, and Injectable), Distribution Channel (Hospital Pharmacies, Retail, and E-commerce), and by Indication (Parasitic Infections, Allergic Infections, and Others) Forecast Period (2024-2031)

Veterinary dermatology drugs market is anticipated to grow at a CAGR of 9.2% during the forecast period (2024-2031). Severe diseases affect a lot of animals worldwide, such as autoimmune skin diseases, parasite skin diseases, dander-related skin disorders, alopecia, and intrinsic skin infections. This is leading to an increased demand for veterinary dermatology drugs. The market growth is also attributed to the rising adoption of pets among the global population. This has positively contributed to the surge in the services and medicines available for companion animal care. The increasing burden of dermatological diseases in pet animals is also contributing to the industry's growth. Furthermore, the market players are actively investing in R&D fueling the market growth.

Market Dynamics

Increasing Pet Ownership

There has been an increase in demand for veterinary dermatology drugs in recent times owing to the growing consciousness of pet owners about the welfare and health of their animals. Moreover, an increasing number of pet owners are recognizing the worth of good skin, and there are greater success levels in treating skin diseases in animals because of advances in veterinary medicine. This is worsened by issues such as climate change and pollution, making it necessary to provide broader access to veterinary treatment that includes enhanced skin special services. Online communities and social media platforms have also contributed to the flow of information and experiences between pet owners, thereby elucidating the pattern.

Rising Skin Diseases in Pets

There are complex connections among various factors such as infections, environmental changes, and parasites that have led to the increase in cases of skin diseases affecting domestic animals including pets and livestock. Parasites, for instance, fleas as well as allergens found in food can make animals develop inflammations such as dermatitis.

Market Segmentation

Our in-depth analysis of the global veterinary dermatology drugs market includes the following segments type, animal type, route of administration, distribution channel, and indication.

Based on type, the market is segmented into antifungal drugs, antibacterial drugs, and antiparasitic drugs.
Based on animal type, the market is bifurcated into companion animals and livestock animals.
Based on the route of administration, the market is segmented into topical, oral, and injectable.
Based on distribution channels, the market is segmented into hospital pharmacies, retail, and e-commerce.
Based on indication, the market is segmented into parasitic infections, allergic infections, and others.

Companion Animal is projected to Emerge as the Largest Segment

The rise in pet ownership has consequently led to an increased need for high-quality pet products and services. This rise has been fueled by an increased understanding of pet requirements due to advancements in veterinary medicine as well as information dissemination on the subject matter. Owners are rendering high preference for high-end pet foods, toys, and other health-related items for animals.

Topical segment to hold a Considerable Market Share

Topical medicines provide high specificity and can be easily applied directly at the affected site without having to be injected into bloodstreams thereby minimizing general body reactions or alterations from other drug elements. Veterinaries prefer topical drugs as they are easier to administer in comparison to oral tablets and suspensions. They deliver faster relief when used on the affected spot and are useful for treating several skin conditions. As consumer need for effective therapy choices rises, the topical segment is leading the way in terms of animal health care solutions innovation focusing on efficacy, safety, as well as ease of use.

Regional Outlook

The global veterinary dermatology drugs market is further segmented based on geography including North America (the US, and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Holds Major Market Share

A larger number of pet owners in North America emphasize specific types of medical care such as dermatological procedures. Consequently, the rise in chemical cures that meet specific demands has been very high. Thus, pharmaceutical enterprises have been involved in research activities to design new drugs to fight against various animal skin illnesses.

Market Players Outlook

The major companies serving the global veterinary dermatology drugs market include Bimeda, Inc., Ceva Sante Animale, Elanco, Merck & Co., Inc., and Zoetis Inc., among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market. For instance, in January 2021, Ceva Animal Health, LLC launched a new skincare brand known as Douxo S3 Pyo for cats and dogs. It is intended to offer a simple way of using antibacterial to enhance moisture content & barrier function in their ecosystem.

Product Code: OMR2028689

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
3.2. Ceva Animal Health, LLC
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. Elanco Animal Health Inc.
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. Merck & Co., Inc.
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. Zoetis Services LLC.
- 3.5.1. Overview
- 3.5.2. Financial Analysis
- 3.5.3. SWOT Analysis
- 3.5.4. Recent Developments
3.6. Key Strategy Analysis

4. Market Segmentation

4.1. Global Veterinary Dermatology Drugs Market by Type
- 4.1.1. Antifungal Drugs
- 4.1.2. Antibacterial Drugs
- 4.1.3. Antiparasitic Drugs
4.2. Global Veterinary Dermatology Drugs Market by Animal Type
- 4.2.1. Companion Animals
- 4.2.2. Livestock Animals
4.3. Global Veterinary Dermatology Drugs Market by Route of Administration
- 4.3.1. Topical
- 4.3.2. Oral
- 4.3.3. Injectable
4.4. Global Veterinary Dermatology Drugs Market by Distribution Channel
- 4.4.1. Hospital Pharmacies
- 4.4.2. Retail
- 4.4.3. E-commerce
4.5. Global Veterinary Dermatology Drugs Market by Indication
- 4.5.1. Parasitic Infections
- 4.5.2. Allergic Infections
- 4.5.3. Others (Skin Cancer)

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
- 5.4.1. Latin America
- 5.4.2. Middle East & Africa

6. Company Profiles

6.1. AB Science
6.2. Bayer AG
6.3. Bimeda Holdings Ltd.
6.4. Bioiberica S.A.U.
6.5. Boehringer Ingelheim International GmbH
6.6. IDEXX Laboratories Inc.
6.7. Indian Immunologicals Ltd.
6.8. Leti Pharma, S.L.U.
6.9. Mars, Inc.
6.10. Novartis AG
6.11. SAVAVET
6.12. Toray Industries, Inc.
6.13. Vetoquinol Group
6.14. Virbac Corp.
6.15. Vivaldis Health & Foods Pvt. Ltd.

Product Code: OMR2028689

LIST OF TABLES

1. Global Veterinary Dermatology Drugs Market Research And Analysis By Type, 2023-2031 ($ Million)
2. Global Antifungal Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
3. Global Antibacterial Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
4. Global Antiparasitic Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
5. Global Veterinary Dermatology Drugs Market Research And Analysis By Animal Type, 2023-2031 ($ Million)
6. Global Veterinary Dermatology Drugs For Companion Animals Market Research And Analysis By Region, 2023-2031 ($ Million)
7. Global Veterinary Dermatology Drugs For Livestock Animals Market Research And Analysis By Region, 2023-2031 ($ Million)
8. Global Veterinary Dermatology Drugs Market Research And Analysis By Route Of Administration, 2023-2031 ($ Million)
9. Global Topical Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
10. Global Oral Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
11. Global Injectable Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
12. Global Veterinary Dermatology Drugs Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
13. Global Veterinary Dermatology Drugs In Hospital Pharmacies Market Research And Analysis By Region, 2023-2031 ($ Million)
14. Global Veterinary Dermatology Drugs In Retail Market Research And Analysis By Region, 2023-2031 ($ Million)
15. Global Veterinary Dermatology Drugs In E-Commerce Market Research And Analysis By Region, 2023-2031 ($ Million)
16. Global Veterinary Dermatology Drugs Market Research And Analysis By Indication, 2023-2031 ($ Million)
17. Global Veterinary Dermatology Drugs For Parasitic Infections Market Research And Analysis By Region, 2023-2031 ($ Million)
18. Global Veterinary Dermatology Drugs For Allergic Infections Market Research And Analysis By Region, 2023-2031 ($ Million)
19. Global Veterinary Dermatology Drugs For Others Market Research And Analysis By Region, 2023-2031 ($ Million)
20. Global Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
21. North American Veterinary Dermatology Drugs Market Research And Analysis By Country, 2023-2031 ($ Million)
22. North American Veterinary Dermatology Drugs Market Research And Analysis By Type, 2023-2031 ($ Million)
23. North American Veterinary Dermatology Drugs Market Research And Analysis By Animal Type, 2023-2031 ($ Million)
24. North American Veterinary Dermatology Drugs Market Research And Analysis By Route Of Administration, 2023-2031 ($ Million)
25. North American Veterinary Dermatology Drugs Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
26. North American Veterinary Dermatology Drugs Market Research And Analysis By Indication, 2023-2031 ($ Million)
27. European Veterinary Dermatology Drugs Market Research And Analysis By Country, 2023-2031 ($ Million)
28. European Veterinary Dermatology Drugs Market Research And Analysis By Type, 2023-2031 ($ Million)
29. European Veterinary Dermatology Drugs Market Research And Analysis By Animal Type, 2023-2031 ($ Million)
30. European Veterinary Dermatology Drugs Market Research And Analysis By Route Of Administration, 2023-2031 ($ Million)
31. European Veterinary Dermatology Drugs Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
32. European Veterinary Dermatology Drugs Market Research And Analysis By Indication, 2023-2031 ($ Million)
33. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Country, 2023-2031 ($ Million)
34. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Type, 2023-2031 ($ Million)
35. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Animal Type, 2023-2031 ($ Million)
36. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Route Of Administration, 2023-2031 ($ Million)
37. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
38. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Indication, 2023-2031 ($ Million)
39. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
40. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Type, 2023-2031 ($ Million)
41. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Animal Type, 2023-2031 ($ Million)
42. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Route Of Administration, 2023-2031 ($ Million)
43. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
44. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Indication, 2023-2031 ($ Million)

LIST OF FIGURES

1. Global Veterinary Dermatology Drugs Market Share By Type, 2023 Vs 2031 (%)
2. Global Antifungal Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
3. Global Antibacterial Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
4. Global Antiparasitic Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
5. Global Veterinary Dermatology Drugs Market Share By Animal Type, 2023 Vs 2031 (%)
6. Global Veterinary Dermatology Drugs For Companion Animals Market Share By Region, 2023 Vs 2031 (%)
7. Global Veterinary Dermatology Drugs For Livestock Animals Market Share By Region, 2023 Vs 2031 (%)
8. Global Veterinary Dermatology Drugs Market Share By Route Of Administration, 2023 Vs 2031 (%)
9. Global Topical Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
10. Global Oral Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
11. Global Injectable Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
12. Global Veterinary Dermatology Drugs Market Share By Distribution Channel, 2023 Vs 2031 (%)
13. Global Veterinary Dermatology Drugs In Hospital Pharmacies Market Share By Region, 2023 Vs 2031 (%)
14. Global Veterinary Dermatology Drugs In Retail Market Share By Region, 2023 Vs 2031 (%)
15. Global Veterinary Dermatology Drugs In E-Commerce Market Share By Region, 2023 Vs 2031 (%)
16. Global Veterinary Dermatology Drugs Market Share By Indication, 2023 Vs 2031 (%)
17. Global Veterinary Dermatology Drugs For Parasitic Infections Market Share By Region, 2023 Vs 2031 (%)
18. Global Veterinary Dermatology Drugs For Allergic Infections Market Share By Region, 2023 Vs 2031 (%)
19. Global Veterinary Dermatology Drugs For Others Market Share By Region, 2023 Vs 2031 (%)
20. Global Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
21. US Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
22. Canada Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
23. UK Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
24. France Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
25. Germany Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
26. Italy Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
27. Spain Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
28. Rest Of Europe Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
29. India Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
30. China Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
31. Japan Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
32. South Korea Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
33. Rest Of Asia-Pacific Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
34. Latin America Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
35. Middle East And Africa Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)